Virgil A. Place
50Patents
32h-index
23Co-inventors
88Inventor score
Filing activity: May 17, 1971 → Oct 28, 2005
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US3964482A | Drug delivery device | Human Necessities | 456 | Expired |
| US5877216A | Treatment of female sexual dysfunction | Performing Operations; Transporting | 236 | Expired |
| US6294550A | Treatment of female sexual dysfunction | Human Necessities | 222 | Expired |
| US6306841A | Treatment of female sexual dysfunction | Human Necessities | 210 | Expired |
| US6037346A | Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction | Human Necessities | 130 | Expired |
| US6469016B1 | Treatment of female sexual dysfunction using phosphodiesterase inhibitors | Human Necessities | 110 | Expired |
| US5910316A | Use of nitric oxide-releasing agents to treat impotency | Chemistry; Metallurgy | 103 | Expired |
| US5242391A | Urethral insert for treatment of erectile dysfunction | Human Necessities | 100 | Expired |
| US7226910B2 | Treatment of female sexual dysfunction with vasoactive intestinal polypeptide agonists | Emerging Cross-Sectional Technologies | 98 | Expired |
| US6117446A | Drug dosage unit for buccal administration of steroidal active agents | Human Necessities | 97 | Expired |
| US6472434B1 | Method for minimizing excess collagen deposition | Human Necessities | 96 | Expired |
| US6127363A | Local administration of Type IV phosphodiesterase inhibitors for the treatment of erectile dysfunction | Human Necessities | 86 | Expired |
| US6403597B1 | Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation | Human Necessities | 68 | Expired |
| US5573776A | Oral osmotic device with hydrogel driving member | Human Necessities | 67 | Expired |
| US6156753A | Local administration of type III phosphodiesterase inhibitors for the treatment of erectile dysfunction | Human Necessities | 66 | Expired |
| US6593313B2 | Co-administration of a prostaglandin and an androgenic agent in the treatment of female sexual dysfunction | Human Necessities | 66 | Expired |
| US5922341A | Local administration of pharmacologically active agents to treat premature ejaculation | Human Necessities | 63 | Expired |
| US5474535A | Dosage and inserter for treatment of erectile dysfunction | Human Necessities | 62 | Expired |
| US5021053A | Oral osmotic device with hydrogel driving member | Human Necessities | 59 | Expired |
| US6284263A | Buccal drug administration in the treatment of female sexual dysfunction | Human Necessities | 55 | Expired |
| US6284262A | Compact dosage unit for buccal administration of a pharmacologically active agent | Human Necessities | 49 | Expired |
| US4725439A | Transdermal drug delivery device | Emerging Cross-Sectional Technologies | 48 | Expired |
| US5147654A | Oral osmotic device for delivering nicotine | Human Necessities | 46 | Expired |
| US6228864A | Administration of 5-HT receptor agonists and antagonists, to treat premature ejaculation | Human Necessities | 43 | Expired |
| US5773020A | Treatment of erectile dysfunction | Human Necessities | 43 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.